Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma

Published:2018-01-29 Issue:1 Volume:6 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Koshkin Vadim S.,Barata Pedro C.,Zhang Tian,George Daniel J.,Atkins Michael B.,Kelly William J.,Vogelzang Nicholas J.,Pal Sumanta K.,Hsu JoAnn,Appleman Leonard J.,Ornstein Moshe C.,Gilligan Timothy,Grivas Petros,Garcia Jorge A.,Rini Brian I.

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-018-0319-9.pdf

Reference20 articles.

1. Patard J-J, Leray E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23:2763–71.

2. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours. Eur Urol. 2016;70:93–105.

3. Giles RH, Choueiri TK, Heng DY, et al. Recommendations for the management of rare kidney cancers. Eur Urol. 2017; https://doi.org/10.1016/j.eururo.2017.06.040 .

4. Vera-Badillo FE, Templeton AJ, Duran I, et al. Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysis. Eur Urol. 2015;67:740–9.

5. Tannir NM, Jonasch E, Albiges L, et al. Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell carcinoma (ESPN): a randomized multicenter phase 2 trial. Eur Urol. 2016;69:866–74.

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes and prognostic factors in metastatic nonclear cell renal cell carcinoma treated with immuno-oncology combination therapy;Japanese Journal of Clinical Oncology;2024-08-23

2. Current Status and Challenges in Rare Genitourinary Cancer Research and Future Directions;Current Oncology Reports;2024-06-07

3. Exploring genes within the glutathione peroxidase family as potential predictors of prognosis in papillary renal cell carcinoma;Oncologie;2024-05-08

4. Papillary Renal Cell Carcinoma: Current Evidence and Future Directions;Kidney Cancer;2024-05-07

5. Cancer immunity by tissue‐resident type 1 innate lymphoid cells and killer innate‐like T cells;Immunological Reviews;2024-03-20